251 related articles for article (PubMed ID: 9154872)
21. Functional similarities of asbestosis and cryptogenic fibrosing alveolitis.
Markos J; Musk AW; Finucane KE
Thorax; 1988 Sep; 43(9):708-14. PubMed ID: 3194877
[TBL] [Abstract][Full Text] [Related]
22. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis.
Renzoni E; Lympany P; Sestini P; Pantelidis P; Wells A; Black C; Welsh K; Bunn C; Knight C; Foley P; du Bois RM
Arthritis Rheum; 2000 Jul; 43(7):1633-40. PubMed ID: 10902769
[TBL] [Abstract][Full Text] [Related]
23. Structural features of interstitial lung disease in systemic sclerosis.
Harrison NK; Myers AR; Corrin B; Soosay G; Dewar A; Black CM; Du Bois RM; Turner-Warwick M
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):706-13. PubMed ID: 1892314
[TBL] [Abstract][Full Text] [Related]
24. Traction bronchiectasis in cryptogenic fibrosing alveolitis: associated computed tomographic features and physiological significance.
Desai SR; Wells AU; Rubens MB; du Bois RM; Hansell DM
Eur Radiol; 2003 Aug; 13(8):1801-8. PubMed ID: 12942282
[TBL] [Abstract][Full Text] [Related]
25. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment.
Wiggins J; Strickland B; Turner-Warwick M
Respir Med; 1990 Sep; 84(5):365-9. PubMed ID: 2247666
[TBL] [Abstract][Full Text] [Related]
26. Density gradient of the lung parenchyma at computed tomographic scanning in patients with pulmonary hypertension and systemic sclerosis.
Cailes JB; du Bois RM; Hansell DM
Acad Radiol; 1996 Sep; 3(9):724-30. PubMed ID: 8883512
[TBL] [Abstract][Full Text] [Related]
27. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis.
Picado C; Gómez de Almeida R; Xaubet A; Montserrat J; Letang E; Sánchez-Lloret J
Respiration; 1985; 48(1):77-80. PubMed ID: 4023442
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
[TBL] [Abstract][Full Text] [Related]
29. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
Sahhar J; Littlejohn G; Conron M
Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
[TBL] [Abstract][Full Text] [Related]
30. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis.
Rajasekaran BA; Shovlin D; Lord P; Kelly CA
Rheumatology (Oxford); 2001 Sep; 40(9):1022-5. PubMed ID: 11561113
[TBL] [Abstract][Full Text] [Related]
31. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
[TBL] [Abstract][Full Text] [Related]
32. Hypothesis: exposure to solvents may cause fibrosing alveolitis.
Billings CG; Howard P
Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888
[TBL] [Abstract][Full Text] [Related]
33. T-cell receptor gene usage in patients with fibrosing alveolitis and control subjects.
Lympany PA; Southcott AM; Welsh KI; Black CM; Boylston AW; du Bois RM
Eur J Clin Invest; 1999 Feb; 29(2):173-81. PubMed ID: 10093005
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT.
Padley SP; Padhani AR; Nicholson A; Hansell DM
Clin Radiol; 1996 Nov; 51(11):807-10. PubMed ID: 8937326
[TBL] [Abstract][Full Text] [Related]
35. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
Montuschi P; Ciabattoni G; Paredi P; Pantelidis P; du Bois RM; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1524-7. PubMed ID: 9817703
[TBL] [Abstract][Full Text] [Related]
36. Fibrosing alveolitis: chest radiography and CT as predictors of clinical and functional impairment at follow-up in 26 patients.
Terriff BA; Kwan SY; Chan-Yeung MM; Müller NL
Radiology; 1992 Aug; 184(2):445-9. PubMed ID: 1620845
[TBL] [Abstract][Full Text] [Related]
37. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
[TBL] [Abstract][Full Text] [Related]
38. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
Tung KT; Wells AU; Rubens MB; Kirk JM; du Bois RM; Hansell DM
Thorax; 1993 Apr; 48(4):334-8. PubMed ID: 8135910
[TBL] [Abstract][Full Text] [Related]
39. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?
Matusiewicz SP; Williamson IJ; Sime PJ; Brown PH; Wenham PR; Crompton GK; Greening AP
Eur Respir J; 1993 Oct; 6(9):1282-6. PubMed ID: 8287944
[TBL] [Abstract][Full Text] [Related]
40. Enlarged mediastinal lymph nodes in the fibrosing alveolitis of systemic sclerosis.
Garber SJ; Wells AU; duBois RM; Hansell DM
Br J Radiol; 1992 Nov; 65(779):983-6. PubMed ID: 1450835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
